The present findings demonstrate a novel function of KLHL3 mutation in extrarenal tissues, such as the liver, and may provide a therapeutic target against obesity and obesity-related diseases. The gene discussed is KLHL3; the disease is obesity due to melanocortin 4 receptor deficiency.